The established risk of prostate cancer comorbidity in BRCA1/2 mutation carriers: where is the clinically relevant hotspot for prostate cancer?

ABSTRACT:

SUBMITTER: Matsumoto T 

PROVIDER: S-EPMC7658146 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature